Below you can find consensus from equity research analysts that currently cover Fluidra's stock (updated on a monthly basis).
FY 2024 (in €M):
| Metric | Min | Max | Average | Contr. |
|---|---|---|---|---|
| Sales | 1,989 | 2,136 | 2,080 | 17 |
| Adjusted EBITDA | 434 | 499 | 467 | 16 |
| Adjusted EBITA | 310 | 407 | 375 | 7 |
| Cash Net Profit | 206 | 253 | 226 | 5 |
| Cash EPS | 1,07 | 1,32 | 1,18 | 7 |
| Net Working Capital | 345 | 497 | 396 | 13 |
| Net Debt | 1,041 | 1,169 | 1,101 | 15 |
FY 2025 (in €M):
| Metric | Min | Max | Average | Contr. |
|---|---|---|---|---|
| Sales | 2,087 | 2,267 | 2,188 | 16 |
| Adjusted EBITDA | 477 | 548 | 515 | 15 |
| Adjusted EBITA | 356 | 454 | 424 | 7 |
| Cash Net Profit | 254 | 291 | 270 | 4 |
| Cash EPS | 1,34 | 1,51 | 1,41 | 6 |
| Net Working Capital | 369 | 527 | 418 | 13 |
| Net Debt | 858 | 1,129 | 983 | 15 |
* Data as of 31.05.2024
Notes:
- A total of 19 analysts cover Fluidra. The consensus presented above includes figures from those analysts who have published updated estimates over the last 6 months (17 analysts).
- The metrics compiled above are consistent with Fluidra's reporting metrics. Fluidra does not alter the figures in any way.